Jeff Sperring Details 'Cancer Moonshot,' New War on Cancer

Jeff Sperring Details 'Cancer Moonshot,' New War on Cancer

President Barack Obama, in his 2016 State of the Union address, called on Vice President Joe Biden to lead a new, national "Cancer Moonshot" program to speed up efforts to prevent, diagnose and treat cancer. The goal is to telescope a decade of advances into five years. Dr. Jeff Sperring, chief executive officer of Seattle Children's Hospital, was among the experts involved in the initiative. He spoke to U.S. News & World Report about the administration's push to conquer cancer and some promising strides in pediatric cancer pioneered at Seattle Children's.

About Seattle Children’s

Seattle Children’s mission is to provide hope, care and cures to help every child live the healthiest and most fulfilling life possible. Together, Seattle Children’s Hospital, Research Institute and Foundation deliver superior patient care, identify new discoveries and treatments through pediatric research, and raise funds to create better futures for patients.

Ranked as one of the top children’s hospitals in the country by U.S. News & World Report, Seattle Children’s serves as the pediatric and adolescent academic medical center for Washington, Alaska, Montana and Idaho – the largest region of any children’s hospital in the country. As one of the nation’s top five pediatric research centers, Seattle Children’s Research Institute is internationally recognized for its work in neurosciences, immunology, cancer, infectious disease, injury prevention and much more. Seattle Children’s Hospital and Research Foundation works with the Seattle Children’s Guild Association, the largest all-volunteer fundraising network for any hospital in the country, to gather community support and raise funds for uncompensated care and research. Join Seattle Children’s bold initiative – It Starts With Yes: The Campaign for Seattle Children’s – to transform children’s health for generations to come.

For more information, visit or follow us on Twitter, Facebook, Instagram or on our On the Pulse blog.